Cargando…
Novel gRNA design pipeline to develop broad-spectrum CRISPR/Cas9 gRNAs for safe targeting of the HIV-1 quasispecies in patients
The CRISPR/Cas9 system has been proposed as a cure strategy for HIV. However, few published guide RNAs (gRNAs) are predicted to cleave the majority of HIV-1 viral quasispecies (vQS) observed within and among patients. We report the design of a novel pipeline to identify gRNAs that target HIV across...
Autores principales: | Sullivan, Neil T., Dampier, Will, Chung, Cheng-Han, Allen, Alexander G., Atkins, Andrew, Pirrone, Vanessa, Homan, Greg, Passic, Shendra, Williams, Jean, Zhong, Wen, Kercher, Katherine, Desimone, Mathew, Li, Luna, C. Antell, Gregory, Mell, Joshua Chang, Ehrlich, Garth D., Szep, Zsofia, Jacobson, Jeffrey M., Nonnemacher, Michael R., Wigdahl, Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6864089/ https://www.ncbi.nlm.nih.gov/pubmed/31745112 http://dx.doi.org/10.1038/s41598-019-52353-9 |
Ejemplares similares
-
HIV-1 Genetic Variation Resulting in the Development of New Quasispecies Continues to Be Encountered in the Peripheral Blood of Well-Suppressed Patients
por: Dampier, Will, et al.
Publicado: (2016) -
Designing broad-spectrum anti-HIV-1 gRNAs to target patient-derived variants
por: Dampier, Will, et al.
Publicado: (2017) -
Evidence of Divergent Amino Acid Usage in Comparative Analyses of R5- and X4-Associated HIV-1 Vpr Sequences
por: Antell, Gregory C., et al.
Publicado: (2017) -
Computational Design of gRNAs Targeting Genetic Variants Across HIV-1 Subtypes for CRISPR-Mediated Antiviral Therapy
por: Chung, Cheng-Han, et al.
Publicado: (2021) -
Utilization of HIV-1 envelope V3 to identify X4- and R5-specific Tat and LTR sequence signatures
por: Antell, Gregory C., et al.
Publicado: (2016)